In conclusion, our in vitro and in vivo results demonstrated that aplysin suppressed the growth of the breast tumor in strong association with an inhibition and targeting of PI3K/AKT, and probably in major part, their downstream FOXO3a pathway. Here, FOXO3 is linked to breast neoplasm.